Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Epigenetics

• Publication date

  2014-08-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/epi.32089PMID 25093535PMCID PMC4169021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.

  2014cited by this paper
• Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

  2013cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Microsatellite instability in colorectal cancer

  2011cited by this paper
• Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status

  2011cited by this paper
• Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia

  2011cited by this paper
• Molecular profiles and clinical outcome of stage UICC II colon cancer patients

  2011cited by this paper
• Microsatellite instability in colorectal cancer—the stable evidence

  2010cited by this paper
• Colorectal cancer molecular biology moves into clinical practice

  2010cited by this paper
• Microsatellite instability in colorectal cancer.

  2010cited by this paper
• A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

  2010cited by this paper
• Neuer Prognosemarker beim invasiven Mammakarzinom

  2008cited by this paper
• Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis

  2008cited by this paper
• Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.

  2008cited by this paper
• Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.

  2008cited by this paper
• The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation

  2008cited by this paper
• CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.

  2008cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Correlation of Pathologic Features With CpG Island Methylator Phenotype (CIMP) by Quantitative DNA Methylation Analysis in Colorectal Carcinoma

  2006cited by this paper
• Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

  2006cited by this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cited by this paper
• New approaches to the adjuvant therapy of colon cancer.

  2006cited by this paper
• ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.

  2004cited by this paper
• CpG island methylator phenotype in cancer

  2004cited by this paper
• Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

  2003cited by this paper
• CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.

  2003cited by this paper
• CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.

  2002cited by this paper
• Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands

  2002cited by this paper
• Are there two sides to colorectal cancer?

  2002cited by this paper
• Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia

  2001cited by this paper
• Mechanisms of oncogenesis in colon versus rectal cancer

  2001cited by this paper
• Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.

  2001cited by this paper
• Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

  2000cited by this paper
• Colorectal cancer.

  1999cited by this paper
• CpG island methylator phenotype in colorectal cancer.

  1999cited by this paper
• Morphology of sporadic colorectal cancer with DNA replication errors

  1998cited by this paper
• Real-time quantitative RT–PCR after laser-assisted cell picking

  1998cited by this paper
• Inhibition of metastasis of lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models

  1995cited by this paper
• Inhibitory Effect of a Conjugate between Human Urokinase and Urinary Trypsin Inhibitor on Tumor Cell Invasion in Vitro(*)

  1995cited by this paper
• A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor.

  1993cited by this paper
• Colorectal cancer

  1993cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper
• Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

  1993cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper

• Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinoma.

  2025cites this paper
• Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction.

  2025cites this paper
• Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response.

  2025cites this paper
• The function of the inter-alpha-trypsin inhibitors in the development of disease

  2024cites this paper
• Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

  2024cites this paper
• Exploring the genetic and epigenetic underpinnings of early-onset cancers: Variant prioritization for long read whole genome sequencing from family cancer pedigrees

  2024cites this paper
• ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration

  2024influential citation
• An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor

  2024influential citation
• High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis

  2024cites this paper
• Genetic deletion of ITIH5 leads to increased development of adipose tissue in mice

  2024cites this paper
• ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro

  2022cites this paper
• The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells

  2021cites this paper
• ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids.

  2021cites this paper
• Metastasis Suppressor Genes in Pancreatic Cancer

  2021cites this paper
• Long noncoding RNA LINC00261 upregulates ITIH5 to impair tumorigenic ability of pancreatic cancer stem cells

  2021cites this paper
• ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4

  2021cites this paper
• Comprehensive analysis of lncRNAs N6-methyladenosine modification in colorectal cancer

  2021cites this paper
• Identification of Transcription Factor/Gene Axis in Colon Cancer Using a Methylome Approach

  2020cites this paper
• ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer

  2020cites this paper
• The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology

  2020cites this paper
• Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

  2020cites this paper
• Identification of Epigenetic Regulation on The Expression of The Aberrant Gene of Kidney Renal Clear Cell Carcinoma Patients Observed in a Specific Race

  2019cites this paper
• Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer

  2019cites this paper
• A Retrospective Analysis of the Cartilage Kunitz Protease Inhibitory Proteins Identifies These as Members of the Inter-α-Trypsin Inhibitor Superfamily with Potential Roles in the Protection of the Articulatory Surface

  2019cites this paper
• Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach

  2018cites this paper
• Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer

  2018cites this paper
• A Retrospective Analysis of the Cartilage and Intervertebral Disc Kunitz Protease Inhibitory Proteins Identifies These as Members of The Inter-α-Trypsin Inhibitor Superfamily with potential roles in the protection of the articulatory surface

  2018cites this paper
• A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism.

  2018cites this paper
• Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus

  2018cites this paper
• ITIH5 induces a shift in TGF‐β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death

  2018cites this paper
• The Role of Inter-Alpha-Trypsin-Inhibitor-Heavy-Chain-5 (ITIH5) in Suppressing Pancreatic Cancer Metastasis

  2018cites this paper
• ITIH5 mediates epigenetic reprogramming of breast cancer cells

  2017cites this paper
• Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis

  2017cites this paper
• Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions

  2017cites this paper
• Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer

  2017cites this paper
• DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis

  2016cites this paper
• [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].

  2016cites this paper
• Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation

  2016cites this paper
• Tumorgenese aus pathologischer Sicht

  2016cites this paper
• Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome

  2015cites this paper